Comments: TN SB2099 | 2017-2018 | 110th General Assembly
Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: (Passed) 2018-04-17 - Comp. became Pub. Ch. 674 [SB2099 Detail]
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: (Passed) 2018-04-17 - Comp. became Pub. Ch. 674 [SB2099 Detail]
Text: Latest bill text (Chaptered) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee SB2099 at this time. | |||||
